Blood

923 papers64 directions
Blood is a long-standing publication venue for hematological research, with active contributions in the corpus spanning from 1973 through 2026. In the context of machine learning and artificial intelligence, the venue focuses on the integration of computational methods with clinical hematology to improve patient outcomes. Its content frequently addresses the development of independent biomarkers for disease prognosis, risk stratification for precision treatment selection, and the identification of molecular regulatory axes to overcome chemotherapy resistance. The venue publishes research on the application of AI-based diagnostic tools, such as those used for identifying myelodysplastic syndromes, and the use of integrated profiling to predict treatment responses in conditions like acute myeloid leukemia. Recent papers also explore technical frameworks for data science in medicine, including the generation of synthetic data over federated learning systems to accelerate personalized medicine. This research often utilizes large-scale data sources, such as nationwide electronic health record databases, to conduct epidemiological studies on conditions like venous thromboembolism. In the broader research community, Blood serves as a platform for addressing the statistical and methodological challenges of applying data science to specialized medicine. This includes investigating the generalizability gap in single-center clinical research and managing statistical power challenges in rare disease studies. Prolific contributors such as Zhixiang Shen, Aaron D. Schimmer, and Véronique Voisin highlight the venue's role in bridging bridging strategies for stem cell transplantation with advanced predictive modeling and microvascular visualization techniques.

Papers by Year

2026 4
2025 99
2024 129
2023 83
2022 72
2021 31
2020 44
2019 40
2018 42
2017 17
2016 30
2015 30
2014 26
2013 30
2012 33
2011 32
2010 24
2009 31
2008 25
2007 13
2006 17
2005 22
2004 15
2003 6
2002 4
2001 8
2000 1
1999 2
1998 2
1997 4
1996 1
1995 1
1993 1
1990 4
1988 1
1987 1
1974 1
1973 1

Top Research Directions

Research directions most represented by papers from this venue.

Viscoelastic Monitoring of Whole Blood Coagulation 2
The Non-Additive Toxicity of Multi-Modal Adjunctive Therapies 2
Targeting the Mechanisms of Cancer Stem Cell Resistance 2
Overcoming Data Scarcity in Rare Disease Research 2
Transcriptional Artifacts and Selective Loss from Tissue Dissociation 1
Quantifying Clinical Relevance Beyond Statistical Significance 1
Molecular Clonal Tracking via Immune Repertoire Sequencing 1
Discovering Driver Pathways via Mutational Mutual Exclusivity 1
The Structural Convergence of Adaptive Immune Repertoires 1
Predicting Therapeutic Efficacy Before Morphological Change 1
Synergistic Innate Immune Activation via Combinatorial Adjuvants 1
Genetic Lineage Tracing for Mapping Cellular Ancestry 1
Mechanisms of Metabolic Drug-Drug Interactions 1
Bioorthogonal Labeling and Chemical Proteomics for Target Identification 1
The Dynamics of Dose Dependent Therapeutic Efficacy 1

Top Authors

AuthorPapers
Zhixiang Shen38
Jane E. Barker19
Hongyu An15
Barbara D. Lam12
Zinaida Good12
Mikel Hernaez11
Bita Sahaf9
Lori Muffly9
Matthew J. Frank9
James Nichols8
Jorge J. Nieva8
Allon M Klein7
Filippo Utro6
Jianqiang Li6
Kahn Rhrissorrakrai6
Meong Hi Son6
Moksha H. Desai6
Saurabh Dahiya6
Zachary Ehlinger6
Andrew R. Rezvani5

Impactful Papers

Papers from this venue that shaped research clusters.

Foundational

Influential

Related Venues

Venues with the most similar research cluster distributions.

Papers

TitleYear
Protein Arginine Methyltransferase 5 (PRMT5) Over-Expression Is Essential for Epstein-Barr Virus-Driven B-Cell Transformation.2012
Results of a Randomized, Open-Label, Phase IIIb Study of 2 Schedules of Decitabine in Higher-Risk Myelodysplastic Syndrome Patients2012
Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT2012
The Protein Tyrosine Phosphatase, Shp2, Positively Contributes to FLT3-ITD-Induced Malignant Disease in Vivo and Co-Localizes with Nuclear Phospho-STAT5 in FLT3-ITD-Expressing Leukemic Cells.2012
Up-Regulation of Heme Oxygenase-1 Is Induced by the Leukemia Stroma-Cell Interaction and Rescues Acute Myeloid Leukaemia (AML) Cells From Cytarabin Induced Cell Death2012
Whole Genome Sequencing On Donor Cell Leukemia in a Patient with Multiple Myeloma Identified Gene Mutations That May Provide Insights to Leukemogenesis.2012
5-Azacytidine Specifically Depletes Regulatory T Cells (Tregs) in Myelodysplastic Syndrome (MDS) Patients2011
Abstracts2011
A Multicenter, Open-Label Study of Posaconazole Oral Suspension in Treatment of Patients with Invasive Fungal Infection Refractory to or Intolerant of First-Line Therapy,2011
A Multicenter, Randomized, Open-Label Study to Evaluate Safety and Efficacy of Posaconazole Vs Fluconazole in the Prophylaxis of Invasive Fungal Infection in a Chinese Population2011
Analysis of Methylation Status of ZAR1, GATA4, CDH22, SOX3, SLC16A5, PFN2, EHD3 and TBPL1 in Hematological Malignancies2011
A novel calcium-binding site of von Willebrand factor A2 domain regulates its cleavage by ADAMTS132011
Author Index Vol. 31, No. 1–3, 20112011
Distinct Metabolic Dependency of Normal and Leukemic Cells in a Mouse Model2011
Efficacy of Reduced Induction Chemotherapy and Early Transplantation in ALL Patients2011
Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells2011
Establishment of Bioluminescence Imaging Based Leukemia In Vivo Model for Preclinical Testing2011
Examining platelet–fibrin interactions during traumatic shock in a swine model using platelet contractile force and clot elastic modulus2011
Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma2011
Functional characterization of CD4+ T cells in aplastic anemia2011
Genome-Wide Aberrant Splicing in Patients with Acute Myeloid Leukemia (AML) Indetifies Potential Novel Targets2011
Identification and characterization of Hoxa9 binding sites in hematopoietic cells2011
IL10-592 CC Genotype In the Donor Is Associated with a Significant Decrease of Relapse Rate and a Significant Increase of Event-Free Survival and Overall Survival After Allogeneic Hematopoietic Stem C2011
Induction of Indoleamine 2,3-Dioxygenase Expression by Interferon-g in Human Mesenchymal Stem Cells Inhibits Graft Versus Host Disease2011
KIT Induced Myeloproliferative Disease Is Dependent on PI3Kinase and SHP2 Phosphatase: Identification of SHP2 As a Druggable Target for Treating MPD and AML2011
Low but sustained coagulation activation ameliorates glucose-induced podocyte apoptosis: protective effect of factor V Leiden in diabetic nephropathy2011
Niche-Based Screening Reveals Leukemia Stem Cell Specific Therapeutics2011
NK Cell Activity Influences Long Term Outcome of Pediatric Leucemias After T Cell Depleted Stem Cell Transplantation,2011
NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation2011
Phase 2 Study of Dasatinib in Chinese Patients (Pts) with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) or Advanced Phase Who Are Resistant to or Intolerant of Imatinib (IM)2011
Role of FDG-PET/CT in Detecting Lymphomatous Bone Marrow Involvement in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma2011
Secondary Central Nervous System Lymphoma: A Single Center Experience2011
Standard Dose Rituximab Plus 2–4 Cycles of Pulse Dexamethasone Is Effective and Tolerable in Treatment of Immune Thrombocytopenia (ITP)2011
Subject Index Vol. 31, No. 1–3, 20112011
T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency2011
Targeting the Cyclin D - CDK4/6 - Rb Axis in Mantle Cell Lymphoma with the Novel Translation Inhibitor Silvestrol,2011
The Therapeutic Effect of Umbilical Mesenchymal Stem Cells Injected Directly Into Medullary Cavity of Ilium to Treat Refractory Aplastic Anemia and Bone Marrow Fibrosis,2011
Using Auto Dendritic Cells Accompanied with CIK Plus Chemotherapy As Consolidation Treatment for 59 Patients with Acute Leukemia2011
A Kinome shRNA Screen to Identify Pathways That Regulate Megakaryocyte Polyploidization and New Targets for Differentiation Therapy2010
Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation2010
A small-molecule inhibitor of D-cyclin transactivation displays preclinical efficacy in myeloma and leukemia via phosphoinositide 3-kinase pathway2010
Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CA2010
Author Index Vol. 30, 20102010
Chemotaxis-Related Factors Are Dysregulated In Bone Marrow Mesenchymal Stem Cells (MSCs) In Multiple Myeloma Patients2010
Clioquinol Arrests Cell Cycle at G1 Phase and Triggers Intrinsic Apoptosis In Myeloma and Leukemia Cells by Inhibiting Histone Deacetylases2010
Formal Foundation of Contribution Semantics and Provenance Computation through Query Rewrite in TRAMP2010
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome2010
Hybrid Renal Replacement Treatment in Acute Pulmonary Edema with Acute Kidney Injury following Multiple Wasp Stings: A Report of 3 Cases2010
Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution2010
Long-Term Outcome Following B-Cell Depletion Therapy with Rituximab In Children and Adults with Immune Thrombocytopenia (ITP)2010

« prev Page 15/19 next »